Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandelin, K.
Right arrow Articles by Wickman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandelin, K.
Right arrow Articles by Wickman, M.

Annals of Surgical Oncology, Vol 5, Issue 2 159-165, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Management, morbidity, and oncologic aspects in 100 consecutive patients with immediate breast reconstruction

K. Sandelin, A. M. Billgren and M. Wickman
Department of General Surgery, Karolinska Hospital, Stockholm, Sweden.

BACKGROUND: Immediate breast reconstruction (IBR) is indicated when breast-conserving surgery is inappropriate and the patient refuses mastectomy as the sole procedure. METHODS: Management, morbidity, and oncologic aspects were studied in 100 consecutive patients treated between 1990 and 1994 with a minimum follow-up time of 2 years. Indications for mastectomy and IBR always were discussed within a multidisciplinary group. Eighty-four patients had primary breast cancer, 12 patients underwent salvage mastectomy for an ipsilateral breast tumor recurrence, two patients had benign breast disease, and two patients underwent prophylactic mastectomy because of familial breast cancer. RESULTS: Saline and silicone gel-filled implants were used predominantly (88%), but free and pedicled TRAM flaps were performed in 12 patients (12%). The overall complication rate was 16%. Seven patients lost their implants, three of whom had been irradiated to the chest wall. Sixty-five patients completed breast reconstruction (nipple and areola) within a median time of 418 days (range 40 to 1471 days). At follow-up, eight patients had locoregional recurrences after a median time of 7.2 months (range 1 to 23 months), and nine patients had died from disseminated breast cancer. CONCLUSION: IBR is time-consuming, but it is well tolerated and does not interfere with oncologic adjuvant treatment. IBR can be performed with low morbidity by a dedicated multidisciplinary team.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
P. Ananian, G. Houvenaeghel, C. Protiere, P. Rouanet, S. Arnaud, J.P. Moatti, A. Tallet, A.C. Braud, and C. Julian-Reynier
Determinants of Patients' Choice of Reconstruction with Mastectomy for Primary Breast Cancer
Ann. Surg. Oncol., August 1, 2004; 11(8): 762 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. N. van Geel, C. M. E. Contant, R. T. J. Wai, P. I. M. Schmitz, A. M. M. Eggermont, and M. M. E. Menke-Pluijmers
Mastectomy by Inverted Drip Incision and Immediate Reconstruction: Data From 510 Cases
Ann. Surg. Oncol., May 1, 2003; 10(4): 389 - 395.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.